Status:
COMPLETED
Prevention of Ischemic Events in Patients With Peripheral Arterial Disease
Lead Sponsor:
KRKA
Collaborating Sponsors:
University Medical Centre Ljubljana
University of Ljubljana School of Medicine, Slovenia
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
40-80 years
Brief Summary
The PID-PAB study aims to test the efficacy of the European Guidelines on Cardiovascular Disease Prevention in patients with peripheral arterial disease. Survival, the rate of major atherothrombotic e...
Detailed Description
The observational study Prevention of Ischemic Events in Patients with Peripheral Arterial Disease by the European Guidelines on Cardiovascular Disease Prevention (Slovenian acronym of the study: PID-...
Eligibility Criteria
Inclusion
- Patients with PAD: ankle-brachial pressure index \<= 0.90
- Controls: palpable pedal pulses, ankle-brachial pressure index 0.91-1.30
Exclusion
- Age \< 40 or \> 80 years at inclusion
- Malignancy with a life expectancy \< 5 years
- Atherothrombotic event within a month before inclusion (acute coronary syndrome, stroke or documented transient ischemic attack, critical limb ischemia)
- pregnancy
Key Trial Info
Start Date :
December 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
1455 Patients enrolled
Trial Details
Trial ID
NCT00761969
Start Date
December 1 2004
End Date
December 1 2014
Last Update
November 17 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Vascular Diseases, University of Ljubljana Medical Center
Ljubljana, Slovenia, 1000